CA72-4 detection targets a tumor-associated glycoprotein highly expressed in gastric and other cancers. This biomarker aids in early diagnosis, prognosis, and monitoring of disease progression. Techniques like chemiluminescence assays and magnetic nanoparticle-based immunoassays provide sensitive, non-invasive detection in serum. CA72-4 testing, often combined with other markers, enhances diagnostic accuracy and supports personalized cancer management strategies.
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek